Banque Pictet & Cie’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,284
Closed -$4.74M 658
2022
Q3
$4.74M Sell
19,284
-1,694
-8% -$457K 0.05% 185
2022
Q2
$5.19K Sell
20,978
-774
-4% -$209K 0.05% 174
2022
Q1
$7.21M Sell
21,752
-9,107
-30% -$2.8M 0.06% 158
2021
Q4
$11.1M Buy
30,859
+25,858
+517% +$8.74M 0.08% 121
2021
Q3
$1.63M Buy
5,001
+574
+13% +$194K 0.02% 220
2021
Q2
$1.38M Buy
4,427
+208
+5% +$63.8K 0.02% 234
2021
Q1
$1.34M Buy
+4,219
New +$1.35M 0.02% 220

Other funds holding ABMD

Banque Pictet & Cie's ABMD Position: Q4 2022 in Review

Banque Pictet & Cie sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 19,284 shares — an estimated $4.74M sold.

Banque Pictet & Cie first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $11.1M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Banque Pictet & Cie reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 19,284 Abiomed Inc shares in Q4 2022, an estimated $4.74M.
  • Banque Pictet & Cie first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • Banque Pictet & Cie's Abiomed Inc position peaked at $11.1M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Banque Pictet & Cie's 13F filing for Q4 2022, filed 6 Feb 2023.